NCT01520038View on ClinicalTrials.gov

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Urothelial Carcinoma of the Bladder
Interventions
RADIATION

Proton therapy

RADIATION

IMRT

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01520038 - Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer | Biotech Hunter | Biotech Hunter